| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > E Books > And The Survey Says |
|
Digg It - And The Survey Says
Stuck with an e-book that offers little insight, or new information for your readers to enjoy? Rest assured you’re not the fi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rst person in the "no new information" rut. In fact, e-books are growing in popularity at a rapid rate, thus authors are writ ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ing them just as fast as readers are gravitating to them. Thus there is a crush of new titles being released in the e-book fo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. rmat with little to no new compelling information. You don’t need a team or researchers, or some worldly experience to write here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe profound e-book full of new and insightful information, all you need is some survey data. For years surveys have been used d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro by researchers to obtain the pulse of their customers. Marketers utilize public survey’s to gain perspective on what advertis ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ing campaigns are effective, and what ones aren’t. Academics have utilized sophisticated surveys for hundreds of years compil easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ing data on every topic imaginable. The universal appeal of the survey lays in its ability to communicate the thoughts, and f nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically elings of a group without forcing them to speak up about it on their own. For the average e-book one can construct a 5 or 6 and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ question survey dealing with their topic choice, and distribute it to small sample of 50 people or more. Depending on the top ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ic, and your target audience, the survey can be conducted by phone, or in person, and often can be filled out with simple ans ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a wers such as “yes” and “no”. Once the survey is completed by the random selection of people, you have yourself some new resea dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ch to write about. Interpreting survey data is a science itself, and I don’t claim to have any genuine knowledge on how to d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin o so, however the results can be as simple to report as you choose. If the author of an e-book decides to write an e-book abo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ut high gas prices, and simply has a 3 question survey dealing with the publics view on gas prices, and who’s to blame, the a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel uthor will easily be able to convey the survey results in the e-book. It can be as simple as “Out of 50 surveys distributed t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the random public, 48 respondents said gas prices are higher then they should be.” By making such a simple observation you c y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products an have endless material to write about. You can speculate why they feel that way, or how to change the problem, or the level . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of anger or enthusiasm they had in answering the questions. No matter how large the new information road block seems to be elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip when trying to write a compelling e-book, drive through it in your hummer style data truck known to authors as survey results tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Behavioral Interviews - A Great Showcase for You The Promotion Factor: Seven Strategies to Promote Yourself and Your Business by Playing Golf Developing a Solid Business Plan - Part I
|